博瑞医药 (688166.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(博瑞医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 63.0053.0059.0065.0064.0060.0064.00
 单季度销售净利率(%) 24.0011.0022.0014.0027.0018.0023.00
 单季度净资产收益率ROE(%) 4.002.003.002.004.003.003.00
 单季度总资产净利率ROA(%) 2.001.001.001.002.001.002.00
单季度财务摘要:
 单季度营业总收入(元) 327,395,843.00282,544,604.00304,937,396.00245,010,133.00271,971,007.00251,977,130.00248,373,219.00
 单季度营业总成本(元) 236,664,604.00233,731,900.00229,202,716.00218,635,577.00180,355,533.00202,896,285.00181,443,132.00
 单季度营业收入(元) 327,395,843.00282,544,604.00304,937,396.00245,010,133.00271,971,007.00251,977,130.00248,373,219.00
 单季度营业利润(元) 84,412,832.0037,938,004.0075,605,621.0029,941,118.0091,379,148.0055,547,562.0065,287,388.00
 单季度利润总额(元) 84,411,707.0037,670,959.0075,605,623.0029,709,583.0091,255,703.0055,942,382.0065,299,554.00
 单季度净利润(元) 78,351,151.0032,344,932.0066,044,612.0033,548,277.0073,773,110.0046,304,694.0057,800,875.00
 单季度归属母公司股东的净利润(元) 82,350,373.0038,670,898.0070,769,470.0041,999,371.0085,622,530.0051,246,881.0060,754,391.00
 单季度经营活动产生的现金流量(元) 47,065,933.0026,702,393.0025,060,123.00105,418,775.00162,119,336.0073,369,226.00-29,648,247.00
 单季度投资活动产生的现金流量(元) -24,398,765.00-103,985,744.00-239,203,199.00-77,612,226.00-125,757,034.00-24,882,621.00-643,324,199.00
 单季度筹资活动产生的现金流量(元) 42,058,221.00-30,798,563.0055,424,115.00480,904,902.0017,160,371.00202,167,868.00664,453,062.00
 单季度现金及现金等价物净增加(元) 61,967,119.00-105,385,982.00-162,465,218.00518,335,817.0058,370,813.00250,564,477.00-8,750,779.00

前瞻产业研究院